MedTrace Logo

Effect of Zinc Carnosine on Intestinal Permeability in Healthy Volunteers

NCT00149149 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2023-10-10

No results posted yet for this study

Summary

Zinc carnosine is a food supplement which is available in the health food shops. The investigators wish to see if it can reduce intestinal swelling in people who take non-steroidal anti-inflammatory (anti-swelling) drugs (NSAIDs: non-steroidal antiinflammatory drug.).

Conditions

  • Healthy

Interventions

OTHER

Zinc Carnosine coadministered with Indomethacin

OTHER

Placebo coadministered with Indomethacin

Sponsors & Collaborators

  • Wexham GI Trust

    collaborator UNKNOWN

  • Imperial College London

    lead OTHER

Principal Investigators

  • Raymond Playford, MD, PhD · Imperial College London

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-05-01
Primary Completion
2006-05-18
Completion
2006-05-18

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00149149 on ClinicalTrials.gov